Viewing Study NCT00430261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:47 AM
Ignite Modification Date: 2026-01-29 @ 9:04 PM
Study NCT ID: NCT00430261
Status: COMPLETED
Last Update Posted: 2010-10-06
First Post: 2007-01-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
Sponsor: Swedish Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
None Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bronchoalveolar carcinoma View
None BAC View
None adenocarcinoma View
None lung cancer View
None oral View
None Stage IIIB and IV lung cancer View
None Any bronchoalveolar carcinoma (BAC) View
None Any adenocarcinoma in a never-smoker View